Abysmal shareholder communication, page-75

Its a trial it has protocol . Your going to have to wait until it's closed out.

The trial has 3 endpoints:-

1) Tolerability ie no adverse events/t toxicity
2) Improves the performance of traditional MRI
3) Is detectable in the nodes with magnetic relaxometry sensor.

The sample size has to be between 10 and 15 cohorts to be statistically valid.
Statistical validity and reliability need to be confirmed.

Thats how formal clinical trials are conducted.

As Bob has said ; the implications for the Company are large as they provide the first proof-of-principle of our targeted nanoparticle technology in the clinical setting.

Not long now